
Viviana A Simon, MD, PhD
About Me
Dr. Simon studies emerging pathogens. She has been awarded several grants from the National Institutes of Health for her investigations of HIV and has received several honors and awards for her work.
Video
Watch a video featuring the Microbiology and Virology PhD Graduate School Program.
Language
English
Position
PROFESSOR | Microbiology, PROFESSOR | Pathology, Molecular and Cell Based Medicine, PROFESSOR | Medicine, Infectious Diseases
Multi-Disciplinary Training Areas
Disease Mechanisms and Therapeutics (DMT), Microbiology [MIC]
Education
Residency, Auguste Viktoria Hospital
, The Rockefeller University
, The Rockefeller University
MD, Humboldt University
PhD, University of Rostock
Awards
2008
Sinsheimer Scholar (Alexandrine and Alexander L. Sinsheimer Fund)
Research
Specific Clinical/Research Interest:
HIV pathogenesis and host-virus interactions
Current Students: Mawuena Binka, Susan Majdak
Postdoctoral Fellows: Marcel Ooms
Research Personnel: Ariana Harari
Summary of Research Studies:
My research focuses on HIV-1 pathogenesis and viral host interactions. Complex organisms evolved both innate and adaptive immune defenses to prevent viral infection and/or dissemination. Recently,it became apparent that a group of constitutively expressed genes can efficiently restrict replication of endogenous and exogenous viruses in a species specific manner. Host cells use DNA/RNA editing enzymes as ways to curb invasion from viruses. For example, human APOBEC3G (APOlipoprotein B Editing Complex 3G) has been shown to be active against exogenous retroviruses (HIV-1, HIV-2, Foamy), endogenous mobile genetic elements (e.g., LTR retrotransposons) and DNA viruses (e.g., Hepatitis B). One of the mode of action of cytidine deaminases is one of extensive mutagenesis. The HIV-1 gene Vif effectively counters the antiretroviral activity of APOBEC3G by inducing its degradation. The nucleotide composition of the HIV-1 genome suggests, however, that protection from host-mediated viral cDNA deamination may not be absolute. We have shown that Vif alleles that fail to degrade APOBEC3G, APOBEC3F or both can be detected in vivo. We speculate that intrinsic restriction mediated by cytidine deaminases contributes to HIV-1 sequence diversification.
Publications
Selected Publications
- Sustained superior humoral immune responses of mRNA vaccines compared to Sputnik V viral vector COVID-19 vaccines in naïve and convalescent populations. Anass Abbad, Brian Lerman, Jordan Ehrenhaus, Diego Sebastian Ojeda, Charles Gleason, Gagandeep Singh, Zain Khalil, Ana Silvia Gonzalez-Reiche, Komal Srivastava, Ana Fernandez Sesma, Andrea Gamarnik, Viviana Simon, Florian Krammer. Vaccine
- Humoral SARS-CoV-2 vaccine responses are durable in solid organ transplant recipients with and without HIV. Meenakshi M. Rana, Brandy Haydel, Gina Carrara, Charles Gleason, Jacob Mauldin, Komal Srivastava, Sander S. Florman, Judith Aberg, Morgan van Kesteren, Jacob Mischka, Juan Manuel Carreño, Gagandeep Singh, Damodara Rao Mendu, Ania Wajnberg, Carlos Cordon-Cardo, Florian Krammer, Viviana Simon. Vaccine
- Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC study. Koji Abe, Tyson H. Holmes, Tran T. Nguyen, Seunghee Kim-Schulze, Ofer Levy, Lindsey R. Baden, Esther Melamed, Lauren I.R. Ehrlich, Grace A. McComsey, Rafick P. Sekaly, Charles B. Cairns, Elias K. Haddad, Albert C. Shaw, David A. Hafler, Ruth R. Montgomery, David B. Corry, Farrah Kheradmand, Mark A. Atkinson, Scott C. Brakenridge, Nelson I. Agudelo Higuita, Jordan P. Metcalf, Catherine L. Hough, William B. Messer, Bali Pulendran, Kari C. Nadeau, Mark M. Davis, Ana Fernandez-Sesma, Viviana Simon, Monica Kraft, Chris Bime, Carolyn S. Calfee, David J. Erle, Joanna Schaenman, Elaine F. Reed, Al Ozonoff, Bjoern Peters, Steven H. Kleinstein, Alison D. Augustine, Joann Diray-Arce, Patrice M. Becker, Nadine Rouphael, Holden T. Maecker. Journal of Immunology